Literature DB >> 23298212

Control of human viral infections by natural killer cells.

Stephanie Jost1, Marcus Altfeld.   

Abstract

Natural killer (NK) cells are effector cells of the innate immune system and are important in the control of viral infections. Their relevance is reflected by the multiple mechanisms evolved by viruses to evade NK cell-mediated immune responses. Over recent years, our understanding of the interplay between NK cell immunity and viral pathogenesis has improved significantly. Here, we review the role of NK cells in the control of four important viral infections in humans: cytomegalovirus, influenza virus, HIV-1, and hepatitis C virus.

Entities:  

Mesh:

Year:  2013        PMID: 23298212     DOI: 10.1146/annurev-immunol-032712-100001

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  183 in total

1.  Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1.

Authors:  Héloïse Quillay; Hicham El Costa; Romain Marlin; Marion Duriez; Claude Cannou; Fabrice Chrétien; Hervé Fernandez; Anne Lebreton; Julien Ighil; Olivier Schwartz; Françoise Barré-Sinoussi; Marie-Thérèse Nugeyre; Elisabeth Menu
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

Review 2.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 3.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 4.  Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Authors:  Juan-Ramón Larrubia; Elia Moreno-Cubero; Joaquín Miquel; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

5.  In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.

Authors:  Kieran Seay; Candice Church; Jian Hua Zheng; Kathryn Deneroff; Christina Ochsenbauer; John C Kappes; Bai Liu; Emily K Jeng; Hing C Wong; Harris Goldstein
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 6.  NK cell trafficking in health and autoimmunity:a comprehensive review.

Authors:  Hui Peng; Zhigang Tian
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

7.  Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.

Authors:  Sebastian Lunemann; Gloria Martrus; Angelique Hölzemer; Anais Chapel; Maja Ziegler; Christian Körner; Wilfredo Garcia Beltran; Mary Carrington; Heiner Wedemeyer; Marcus Altfeld
Journal:  J Hepatol       Date:  2016-04-04       Impact factor: 25.083

8.  HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells.

Authors:  Christian Körner; Camille R Simoneau; Philipp Schommers; Mitchell Granoff; Maja Ziegler; Angelique Hölzemer; Sebastian Lunemann; Janet Chukwukelu; Björn Corleis; Vivek Naranbhai; Douglas S Kwon; Eileen P Scully; Stephanie Jost; Frank Kirchhoff; Mary Carrington; Marcus Altfeld
Journal:  Cell Host Microbe       Date:  2017-07-12       Impact factor: 21.023

Review 9.  Innate immunity against HIV-1 infection.

Authors:  Marcus Altfeld; Michael Gale
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

10.  Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Authors:  Tobias A W Holderried; Philipp A Lang; Hye-Jung Kim; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.